Objectives-To investigate the accuracy and reliability of 3-dimensional (3D) transvaginal sonography in classifying submucous fibroids using the International Federation of Gynecology and Obstetrics PALM-COEIN (polyp, adenomyosis, leiomyoma, malignancy and hyperplasia, coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, and not yet classified) classification and protrusion (percent) compared to 2-dimensional (2D) transvaginal sonography, 2D saline infusion sonography, and 3D saline infusion sonography, using hysteroscopy as a reference test.
U terine fibroids are benign monoclonal tumors arising from smooth muscle cells of the uterus, with a reported prevalence as high as 77%. 1 Uterine fibroids are symptomatic in up to 50% of affected women, with submucous fibroids being the most common cause of heavy menstrual bleeding, occurring in 30% of symptomatic women. [2] [3] [4] Fibroids can be classified according to their location in the uterus, using the International Federation of Gynecology and Obstetrics (FIGO) PALM-COEIN (polyp, adenomyosis, leiomyoma, malignancy and hyperplasia, coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, and not yet classified) classification. 5 Submucous fibroids are then subdivided into type 0 (completely intracavitary), type 1 (>50% intracavitary), and type 2 (50% intracavitary). In hysteroscopic treatment of submucous fibroids, higher success rates are achieved for fibroids with greater intracavitary protrusion. 6 Correct classification of submucous fibroids allows women and their gynecologists to make optimal therapeutic decisions regarding medical or surgical management.
Classification of submucous fibroids can be accomplished by transvaginal sonography. With real-time 2-dimensional (2D) transvaginal sonography, protrusion can easily be underestimated or overestimated by viewing the uterine cavity and fibroid in an incorrect plane. With 3-dimensional (3D) transvaginal sonography, this problem can be overcome if using a standardized measurement protocol. 2, 7 Both 2D and 3D transvaginal sonography can be combined with saline infusion sonography to improve the contrast between the myometrium, fibroid, and uterine cavity; however, this procedure is more invasive and can be painful. 8 Furthermore, saline infusion sonography cannot be executed during the luteal cycle phase in fertile women without previous use of contraceptive methods. In the current literature, it is established that 2D transvaginal sonography is less accurate than 2D saline infusion sonography and hysteroscopy in detecting intrauterine lesions, including classifying submucous fibroids. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In treatment of submucous fibroids, the protrusion, diameter, and size of the fibroid's intramural component measured with 3D saline infusion sonography are associated with the likelihood of successful fibroid resection. 19 Currently, the general workup of patients with submucous fibroids consists of 2D transvaginal sonography and 2D saline infusion sonography. Three-dimensional transvaginal sonography and 3D saline infusion sonography are not incorporated in current practice. Regarding submucous fibroids, 3D transvaginal sonography has not yet been studied. Since transvaginal sonography is less invasive than saline infusion sonography, it is worth examining whether 3D transvaginal sonography is equally as accurate as 2D saline infusion sonography in classifying submucous fibroids. If so, saline infusion sonography can be omitted.
We hypothesized that 3D transvaginal sonography would be more accurate than 2D transvaginal sonography in classifying fibroids and just as accurate as 2D saline infusion sonography, using hysteroscopy as a reference test. The collection and analysis of these preliminary data enable a decision of whether a larger diagnostic trial should be considered.
Materials and Methods
A prospective cohort pilot study was performed among 15 consecutive patients undergoing hysteroscopic myomectomy (13 patients) or fibroid ablation (Sonata; Gynesonics, Inc, Redwood City, CA) after diagnostic hysteroscopy (2 patients) from December 2014 until July 2015 at the Gynecology Department of the VU Medical Center. All participating patients gave their consent. The study was approved by the Ethical Board of the VU Medical Center.
Sonography and Hysteroscopy
All surgery was performed under general anesthesia. Before surgery, a routine transvaginal sonographic evaluation of fibroids was performed to evaluate the size, type, and location of fibroids (Accuvix A30 and WS80A; Samsung Medison, Seoul, Korea). Both 2D imaging and storage of the 3D image volumes were performed for transvaginal sonography and saline infusion sonography. The 2D real-time sonographic evaluation and 3D volume recording were executed by 1 of 5 gynecologists performing the hysteroscopic surgery. The 3D sonographic evaluation was performed at a later time by 2 sonographers (A.L.K. and H.A.M.B.) experienced in 3D offline analysis of sonographic volumes. All examinations were performed under general anesthesia before hysteroscopic surgery. First, a 2D sonographic evaluation using a standard transvaginal transducer (5-9 MHz) was performed, and parameters were registered. Endometrial thickness and fibroid size were measured live on screen, and the type and percentage of protrusion were determined by estimation. Second a 3D volume of the entire uterus was recorded with a 3D transvaginal transducer probe. After intrauterine installation of a 0.9% solution of sodium chloride using a Goldstein sonohysterographic catheter (Cook Medical, Bloomington, IN), the 2D sonographic evaluation was repeated using a standard transvaginal transducer; parameters were registered; and another 3D volume of the entire uterus was recorded. Hysteroscopy was performed or supervised by 1 of 5 gynecologists, all experienced in advanced hysteroscopic resections.
During hysteroscopy, uterine cavity and fibroid protrusion were observed with and without intrauterine pressure (60-100 mm Hg). The duration of the procedure and total fluid loss were registered. The performing gynecologist recorded the size, type, and location of the fibroid for 2D transvaginal sonography, 2D saline infusion sonography, and hysteroscopy, the estimated percentage of protrusion, and the interpretability of the examinations, using a case report form. Interpretability was scored on a 4-point scale (1, not interpretable; 2, moderate; 3, good; and 4, very good). Mean scores were calculated for each imaging modality.
Offline Evaluation of 3D Imaging
An offline analysis of 3D transvaginal sonography and 3D saline infusion sonography was performed by 2 examiners (investigators A and B) using virtual organ computer-aided analysis software and a Samsung 3D viewer. Both investigators were blinded to prior sonograms and surgical results and separately analyzed 3D transvaginal sonography as well as 3D saline infusion sonography in a multiplanar view. Data were coded, and a case report form was used to register the size, type, location, and percentage of protrusion of the fibroid on 3D transvaginal sonography and 3D saline infusion sonography and the interpretability of 3D transvaginal sonography and 3D saline infusion sonography. To determine the fibroid location (and measure endometrial thickness), all 3D volumes were scanned in the sagittal plane, containing a clear depiction of the endocervical canal and the uterine cavity and viewed in a standard (3D region of interest) setting. To measure the size and protrusion (and subsequently determine the type), the largest diameter of the fibroid was selected in the sagittal plane. The intersection point of 2 rotation axes (x and y) was placed in the center of the fibroid. While the image was rotated on the x-or y-axis, the largest visible protrusion in a FIGO PALM-COEIN type 0 or 1 fibroid and the largest myometrial extension in a type 2 fibroid could be considered as the true protrusion and extension ( Figure 1 ). The interpretability of 2D transvaginal sonography, 2D saline infusion sonography, and hysteroscopy was scored separately by the performing gynecologist, and the interpretability of 3D transvaginal sonography and 3D saline infusion sonography was scored by both investigators performing offline analysis on a 4-point scale (1, not interpretable; 2, moderate; 3, good; and 4, very good). Mean scores were calculated for each imaging modality.
Statistical Analyses
All analyses were performed by A.L.K. and J.W.R.T. using the SPSS version 22.0 software package (IBM Corporation, Armonk, NY). Main outcome parameters were the agreements of the percentages of intracavitary fibroid protrusion on 2D transvaginal sonography, 2D saline infusion sonography, 3D transvaginal sonography, and 3D saline infusion sonography with hysteroscopy. Intraclass correlation coefficients (ICCs) and BlandAltman plots were constructed to calculate intertest (for 2D transvaginal sonography, 2D saline infusion sonography, 3D transvaginal sonography, and 3D saline infusion sonography compared to hysteroscopy) and interobserver agreement (for 3D transvaginal sonography and 3D saline infusion sonography). An ICC of 0.9 or higher was considered good agreement.
To make a more general comparison between the different types of sonography and hysteroscopy, the j Figure 1 . A, Anteflected uterus on 3D transvaginal sonography without intracavitary contrast in the midsagittal plane. The endometrium and endocervical canal are hyperechoic compared to the myometrium and fibroid. The fibroid is marked in the middle with a green dot. A 3.6-cm fibroid in the posterior uterine wall protrudes 1.23/3.59 3 100% 5 34%, FIGO staging the fibroid as type 2. B, After rotation of the image 90 8 on the x-axis to the coronal plane, the fibroid, marked in the middle with a yellow dot, is completely surrounded by the myometrium, indicating that most of the fibroid is intramural.
value of the estimated type of fibroid ( or > 50% protrusion) on sonography and sonohysterography was compared to the estimated type of fibroid on hysteroscopy. A j of 0.8 was considered good agreement. With the objective that low imaging quality on 3D transvaginal sonography would qualify patients to undergo 3D saline infusion sonography, uninterpretable 3D transvaginal sonograms were excluded, and ICCs were recalculated. Ordinal logistic regression analyses were performed for endometrial thickness as measured on 2D transvaginal sonography (to eliminate any errors in measurement between investigators A and B) and the interpretability of 3D transvaginal sonography scored on a 4-point scale by both investigators A and B.
Results

Baseline Characteristics
One patient was excluded for incomplete data. Fourteen women were included; all were premenopausal, with a mean age of 42 (range, 36-51) years. Oral contraceptives were used in 29% of the women. Parity ranged from 0 to 2. Presenting symptoms were abnormal uterine bleeding (85.7%), abdominal pain (7.1%) and subfertility (7.1%).
Fibroid Characteristics
Thirteen patients had 1 fibroid, and 1 patient had 2 fibroids (the second fibroid was disregarded). For other fibroid characteristics, see Table 1 .
Intraclass Correlation Coefficients of the Percentage of Protrusion Compared to Hysteroscopy
The ICCs of the estimated percentages of protrusion on transvaginal sonography or sonohysterography were compared to hysteroscopy as a reference (Table 2) . Protrusion was estimated to be slightly larger, and the angle between the fibroid and myometrium was estimated to be slightly smaller without intrauterine pressure (results not shown). Protrusion during hysteroscopy with intrauterine pressure of a maximum of 100 mm Hg was chosen as the main reference test, because distension is indispensable in performing hysteroscopy. We also compared the results to hysteroscopy with (Table 1) , which were scored slightly better.
Interobserver Agreement for 3D Transvaginal Sonography and Interpretability
Interpretability was scored on a 4-point scale (1, not interpretable; 2, moderate; 3, good; and 4, very good; Table 3 ). Excluding uninterpretable and moderately interpretable 3D transvaginal sonograms as scored by at least 1 of the investigators (n 5 8) did not improve the interobserver agreement (results not shown). The interpretability of 3D transvaginal sonography seemed to be better with increasing endometrial thickness (odds ratio, 1.34; 95% CI, 0.80, 2.26; P 5 .272 for investigator A; odds ratio, 1.27; 95% CI, 0.76, 2.13; P 5 .361 for investigator B), although the results were not statistically significant.
Underestimation and Overestimation of Protrusion
Protrusion scored using 3D transvaginal sonography by investigators A and B showed that approximately half of Figure 3 . A, Bland-Altman plot of the interobserver agreement for 3D transvaginal sonography (TVS). B, Bland-Altman plot of the interobserver agreement for 3D saline infusion sonography (SIS). Protrusion was transformed to a 3-point ordinal scale. For correct estimation, a difference of 620% compared to hysteroscopy (pressure on) was accepted.
the protrusions were estimated correctly (a maximum of 20% less or more protrusion than on hysteroscopy); one-fourth were underestimated; and one-fourth were overestimated (Table 4) . For investigator A, 50% of the overestimated protrusions (2 of 4) and 75% of the underestimated protrusions (3 of 4) led to an adjustment in the fibroid type. For investigator B, 75% of the overestimated protrusions (3 of 4) and 66% of the underestimated protrusions (2 of 3) led to an adjustment in the fibroid type.
Discussion
Main Findings
Three-dimensional transvaginal sonography was equivalent to 2D transvaginal sonography but not as accurate as 2D saline infusion sonography or 3D saline infusion sonography in estimating the percentage of protrusion compared to hysteroscopy. Correct estimation (620%) was achieved in half of the fibroids only with 3D transvaginal sonography, but this rate improved with increasing endometrial thickness.
Interobserver agreement for 3D transvaginal sonography was moderate and seemed to be better with a greater percentage of the fibroid protruding into the uterine cavity. Interobserver agreement of 3D saline infusion sonography was good and seemed slightly better for smaller portions of the fibroid protruding into the uterine cavity.
Strengths and Limitations
To our knowledge, no previous studies investigating the agreement of 2D transvaginal sonography, 2D saline infusion sonography, 3D transvaginal sonography, and 3D saline infusion sonography with hysteroscopy simultaneously have been reported. The obvious limitation of this pilot study was the small number of patients. As this study was set up as a pilot study, the sample size was not powered to detect significant differences. The hysteroscopic surgeon was not blinded for (previous) 2D transvaginal sonographic and 2D saline infusion sonographic results. In preparing for surgery, the surgeon had access to the patient's medical record, including descriptions and previous sonograms, and additionally, the surgeon performing hysteroscopy also performed the 2D transvaginal sonography and 2D saline infusion sonography beforehand. This factor could have caused a bias in scoring the protrusion during hysteroscopy, and the agreement of 2D transvaginal sonography and 2D saline infusion sonography with hysteroscopy could therefore have been overestimated. Investigators performing offline analyses of coded 3D sweeps were blinded to previous results; however, 3D transvaginal and 3D saline infusion sonograms of the same patient were reviewed in a consecutive manner. Interobserver agreement was only tested for 3D transvaginal sonography and 3D saline infusion sonography, for which both offline examiners analyzed all patients. Interobserver agreement was not investigated for 2D transvaginal sonography or 2D saline infusion sonography. Since these techniques are standard practice, they are assumed to have low interobserver variability, and because of the high number of investigators (5) and the limited number of patients (14) in this pilot study, investigation of the interobserver agreement for 2D transvaginal sonography and 2D saline infusion sonography was deemed not feasible. However, this factor should be a point of focus for future research. Interpretability seems to be better with increasing endometrial thickness; however, the results were not statistically significant, most likely because of the small study population.
Comparison With Available Literature
In this pilot study, 3D transvaginal sonography was equivalent to 2D transvaginal sonography but not as accurate as 2D saline infusion sonography or 3D saline infusion sonography in estimating the percentage of protrusion compared to hysteroscopy. Many studies have investigated the accuracy and reliability of 3D saline infusion sonography, with results that were comparable with ours. Three-dimensional saline infusion sonography offers adequate visualization and characterization of intrauterine abnormalities and is reported to be a reproducible method for the quantification of the percentage of protrusion of a submucous fibroid. 2, [20] [21] [22] [23] [24] [25] Unfortunately, 3D transvaginal sonography is not widely investigated.
Visual inspection of the Bland-Altman plots shows that a smaller percentage of a fibroid protruding into the uterine cavity is inclined to be overestimated on 3D transvaginal sonography compared to hysteroscopy, and a larger percentage of a fibroid protruding into the uterine cavity is inclined to be underestimated. Threedimensional saline infusion sonography is reported to have better overall agreement with hysteroscopy in cases in which a greater proportion of the fibroid is contained within the uterine cavity. 26 In contrast, we did not find a major difference. This study showed moderate interobserver agreement for 3D transvaginal sonography and good interobserver agreement for 3D saline infusion sonography in measuring the percentage of protrusion. These findings are in concordance with the reported literature. In diagnosing uterine fibroids specifically, the interobserver and intraobserver agreement of 3D saline infusion sonography are moderate to good for fibroid protrusion into the uterine cavity. 2, 25 After visual inspection of the Bland-Altman plots, the interobserver agreement of 3D transvaginal sonography seemed to increase with a greater percentage of a fibroid protruding into the uterine cavity, and the interobserver agreement of 3D saline infusion sonography seemed slightly better for smaller portions of a fibroid protruding into the uterine cavity.
Clinical Consequences and Conclusions
Concerning 3D transvaginal sonography (and, to a lesser extent, also 3D saline infusion sonography), visual inspection of the Bland-Altman plots shows that fibroid protrusion of less than 50% was generally overestimated, and fibroid protrusion of greater than 50% was generally underestimated by both investigators compared to hysteroscopy. These findings might have been due to difficulties in distinguishing the uterine cavity from the fibroid capsule, especially when the endometrial lining was thin. Correct estimation seems to be easier with increasing endometrial thickness. A possible reason for overestimation of the protrusion on 3D transvaginal sonography, without saline as a contrast medium, is the possible confusion between endometrial depiction, which is mostly more echogenic than the myometrium or fibroid, and the intramural pseudocapsule of the fibroid, which also appears as a hyperechoic line. Another reason might be the difference between inclusion of the endometrium in the protrusion on 3D transvaginal sonography, especially when it is thick, and exclusion of the endometrium in the protrusion on 3D saline infusion sonography. Finally, the effect of distension of the uterine cavity, which is not applied in 3D transvaginal sonography, on fibroid protrusion is not well known. The protrusion may increase while there is no distending counterforce, but it may also decrease without low-resistance distention of the cavity. In a case of underestimation of the protrusion on 3D transvaginal sonography, the endometrium is not identified properly because of low thickness or ultrasound artifacts such as shadowing. Overestimation of the protrusion could theoretically lead to a more complicated fibroid resection. Taking the above into account, there might be room for improvement, especially in overestimation of the protrusion. In a case of a thin endometrium, an adequate evaluation of the cavity becomes problematic, and saline infusion sonography should be considered.
These preliminary data do not allow firm conclusions on the accuracy of 3D transvaginal sonography for classifying submucous fibroids. Two-dimensional saline infusion sonography and 3D saline infusion sonography, as well as hysteroscopy, remain the reference standards for assessing fibroid protrusion. A larger-scale study is needed to draw more definite conclusions, using the data from this pilot study to refine the diagnostic criteria and protocol, possibly making saline infusion sonography redundant in a substantial number of patients in the future.
